Scott Myers - Oct 1, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Oct 1, 2023
Transactions value $
$0
Form type
4
Date filed
10/2/2023, 05:36 PM
Previous filing
Jul 6, 2023
Next filing
Nov 15, 2023
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). The fully vested RSUs were granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $23,875.
F2 Shares reflect 1:10 reverse stock split effective September 1, 2023.